Homepage

Biosimilars
Stories / Access to Medicines

Improving access to biologic medicines through biosimilars

For a growing range of therapeutic areas, biosimilars make state-of-the-art treatment more affordable ...

Read More
our-mission-and-purpose

Our Mission and Purpose

We are a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine
Read More
Stories / Access to Healthcare

Better access to healthcare through mobile technology: Winning ideas from the Sandoz HACk (17 min read)

A look behind the scenes of the 2017 Sandoz HACk – Healthcare Access Challenge to meet the winners, ...

Read More

Explore Novartis

About Us
Who We Are
Our Work
What We Do
About Us
Corporate Responsibility
Careers
Job Search

Recent Updates

Featured / Jun 20

New data highlights growing role of generic medicines in keeping healthcare sustainable

New data just released in the two largest global pharma markets show the substantial and growing level of savings ...

Learn More
View All
Featured News / Jun 20

New data highlights growing role of generic medicines in keeping healthcare sustainable

New data just released in the two largest global pharma ...

Read More
Media Release / Jun 19

Sandoz receives approval in Europe for Rixathon® (biosimilar rituximab) to treat blood cancers and immunological diseases

Read More
Media Release / Jun 13

US Supreme Court rules in favor of Sandoz in biosimilars case, enabling earlier access to potentially life-saving medicines

Read More
View All
If you’re at #EHA2017, join #biosimilars for Haematologic Malignancies: The Path to Sustainable Care session today at 17:15 at room nr.103 34 min 53 sec ago

Our Work

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.

Learn More